Irvin Rosenfeld is an American medical cannabis patient who is known for being one of the longest-serving medical cannabis patients in the United States. He was diagnosed with a rare bone tumor disorder called multiple congenital cartilaginous exostoses (MCCE) in the 1970s and was prescribed cannabis by the Federal Government as part of the Compassionate Investigational New Drug program.

The program, which was run by the federal government, provided cannabis to a small group of patients suffering from various illnesses such as cancer, glaucoma, and multiple sclerosis. Irvin was one of the first patients to be accepted into the program and has been receiving a steady supply of cannabis from the government for over 35 years.

Irvin is a strong advocate for the use of medical cannabis and has been speaking out about the benefits of the drug for many years. He has been featured in several documentaries and news articles and has even testified before Congress about the effectiveness of cannabis as a medicine.

Despite the success of the Compassionate Investigational New Drug program, it was closed in 1992, and Irvin and the remaining patients were allowed to continue receiving cannabis through the “Investigational New Drug” program.

Irvin’s story is a powerful example of how cannabis can be used as a medicine and the importance of research and access to medical cannabis for patients. His longevity on the program and the lack of alternative treatments available to him, highlights the need for further research on the medical benefits of cannabis and the importance of expanding access to medical cannabis for patients who could benefit from it.